Medical comorbidities increase the rate of surgical site infection in primary Achilles tendon repair
Malcolm E. Dombrowski, MaCalus V. Hogan(University of Pittsburgh), Antonia F. Chen(Brigham and Women's Hospital), Youichi Yasui(Teikyo University), Mitchell S. Fourman(Albert Einstein College of Medicine), Samuel O. Ewalefo(University of Pittsburgh), John G. Kennedy(NYU Langone Health), Christopher D. Murawski(OrthoCarolina)
Cited by 25
Related Papers
Peripheral Nerve Repair and Reconstruction
|Journal of Bone and Joint Surgery|2013|316
Lesion Size Is a Predictor of Clinical Outcomes After Bone Marrow Stimulation for Osteochondral Lesions of the Talus: A Systematic Review
|The American Journal of Sports Medicine|2016|288
The differential effects of leukocyte-containing and pure platelet-rich plasma (PRP) on tendon stem/progenitor cells - implications of PRP application for the clinical treatment of tendon injuries
|Stem Cell Research & Therapy|2015|185
Adipose-Derived Mesenchymal Stem Cells Treated with Growth Differentiation Factor-5 Express Tendon-Specific Markers
|Tissue Engineering Part A|2010|156
Arthroscopic Bone Marrow Stimulation and Concentrated Bone Marrow Aspirate for Osteochondral Lesions of the Talus: A Case‐Control Study of Functional and Magnetic Resonance Observation of Cartilage Repair Tissue Outcomes
|Arthroscopy The Journal of Arthroscopic and Related Surgery|2015|123